Loading…

Genetic determination of exocrine pancreatic function in cystic fibrosis

We showed elsewhere that the pancreatic function status of cystic fibrosis (CF) patients could be correlated to mutations in the CF transmembrane conductance regulator (CFTR) gene. Although the majority of CF mutations--including the most common, delta F508--strongly correlated with pancreatic insuf...

Full description

Saved in:
Bibliographic Details
Published in:American journal of human genetics 1992-06, Vol.50 (6), p.1178-1184
Main Authors: Kristidis, P, Bozon, D, Corey, M, Markiewicz, D, Rommens, J, Tsui, L C, Durie, P
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1184
container_issue 6
container_start_page 1178
container_title American journal of human genetics
container_volume 50
creator Kristidis, P
Bozon, D
Corey, M
Markiewicz, D
Rommens, J
Tsui, L C
Durie, P
description We showed elsewhere that the pancreatic function status of cystic fibrosis (CF) patients could be correlated to mutations in the CF transmembrane conductance regulator (CFTR) gene. Although the majority of CF mutations--including the most common, delta F508--strongly correlated with pancreatic insufficiency (PI), approximately 10% of the mutant alleles may confer pancreatic sufficiency (PS). To extend this observation, genomic DNA of 538 CF patients with well-documented pancreatic function status were analyzed for a series of known mutations in their CFTR genes. Only 20 of the 25 mutations tested were found in this population. They accounted for 84% of the CF chromosomes, with delta F508 being the most frequent (71%), and the other mutations accounted for less than 5% each. A total of 30 different, complete genotypes could be determined in 394 (73%) of the patients. The data showed that each genotype was associated only with PI or only with PS, but not with both. This result is thus consistent with the hypothesis that PI and PS in CF are predisposed by the genotype at the CFTR locus; the PS phenotype occurs in patients who have one or two mild CFTR mutations, such as R117H, R334W, R347P, A455E, and P574H, whereas the PI phenotype occurs in patients with two severe alleles, such as delta F508, delta I507, Q493X, G542X, R553X, W1282X, 621 + 1G---T, 1717-1G---A, 556delA, 3659delC, I148T, G480C, V520F, G551D, and R560T.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1682557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72976162</sourcerecordid><originalsourceid>FETCH-LOGICAL-p292t-44122e4e1bb0ac9e42a9956362df6773e8a7be38165c854ab863f6f36d85406c3</originalsourceid><addsrcrecordid>eNqFkE9LxDAUxIMoa139CEJP3gr507y0F0EW3RUWvOi5pOmrRtqkJq243966LqInT495M_wY5ogkTAqVAVB5TBJKKc9KXqpTchbjK6WMFVQsyIIJBZRBQjZrdDhakzY4Yuit06P1LvVtih_eBOswHbQzAfVXqJ2c2fvWpWYX9y9bBx9tPCcnre4iXhzukjzd3T6uNtn2YX2_utlmAy_5mOU54xxzZHVNtSkx57osJQjgTQtKCSy0qlEUDKQpZK7rAkQLrYBmVhSMWJLrb-4w1T02Bt0YdFcNwfY67CqvbfXXcfalevbvFYOCS6lmwNUBEPzbhHGsehsNdp126KdYqXkuYMD_Dc4ZYHLec0kuf1f66XIYWXwC60V6sg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16261580</pqid></control><display><type>article</type><title>Genetic determination of exocrine pancreatic function in cystic fibrosis</title><source>Open Access: PubMed Central</source><creator>Kristidis, P ; Bozon, D ; Corey, M ; Markiewicz, D ; Rommens, J ; Tsui, L C ; Durie, P</creator><creatorcontrib>Kristidis, P ; Bozon, D ; Corey, M ; Markiewicz, D ; Rommens, J ; Tsui, L C ; Durie, P</creatorcontrib><description>We showed elsewhere that the pancreatic function status of cystic fibrosis (CF) patients could be correlated to mutations in the CF transmembrane conductance regulator (CFTR) gene. Although the majority of CF mutations--including the most common, delta F508--strongly correlated with pancreatic insufficiency (PI), approximately 10% of the mutant alleles may confer pancreatic sufficiency (PS). To extend this observation, genomic DNA of 538 CF patients with well-documented pancreatic function status were analyzed for a series of known mutations in their CFTR genes. Only 20 of the 25 mutations tested were found in this population. They accounted for 84% of the CF chromosomes, with delta F508 being the most frequent (71%), and the other mutations accounted for less than 5% each. A total of 30 different, complete genotypes could be determined in 394 (73%) of the patients. The data showed that each genotype was associated only with PI or only with PS, but not with both. This result is thus consistent with the hypothesis that PI and PS in CF are predisposed by the genotype at the CFTR locus; the PS phenotype occurs in patients who have one or two mild CFTR mutations, such as R117H, R334W, R347P, A455E, and P574H, whereas the PI phenotype occurs in patients with two severe alleles, such as delta F508, delta I507, Q493X, G542X, R553X, W1282X, 621 + 1G---T, 1717-1G---A, 556delA, 3659delC, I148T, G480C, V520F, G551D, and R560T.</description><identifier>ISSN: 0002-9297</identifier><identifier>EISSN: 1537-6605</identifier><identifier>PMID: 1376016</identifier><language>eng</language><publisher>United States</publisher><subject>Alleles ; Amino Acid Sequence ; Child ; Chromosome Deletion ; Chromosome Mapping ; Codon - genetics ; cystic fibrosis ; Cystic Fibrosis - genetics ; Cystic Fibrosis - physiopathology ; Cystic Fibrosis Transmembrane Conductance Regulator ; DNA - genetics ; Exons ; Frameshift Mutation ; function ; Genotype ; Humans ; Introns ; man ; Membrane Proteins - genetics ; Mutation ; mutations ; pancreas ; Pancreas - physiopathology ; phenotypes</subject><ispartof>American journal of human genetics, 1992-06, Vol.50 (6), p.1178-1184</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682557/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682557/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1376016$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kristidis, P</creatorcontrib><creatorcontrib>Bozon, D</creatorcontrib><creatorcontrib>Corey, M</creatorcontrib><creatorcontrib>Markiewicz, D</creatorcontrib><creatorcontrib>Rommens, J</creatorcontrib><creatorcontrib>Tsui, L C</creatorcontrib><creatorcontrib>Durie, P</creatorcontrib><title>Genetic determination of exocrine pancreatic function in cystic fibrosis</title><title>American journal of human genetics</title><addtitle>Am J Hum Genet</addtitle><description>We showed elsewhere that the pancreatic function status of cystic fibrosis (CF) patients could be correlated to mutations in the CF transmembrane conductance regulator (CFTR) gene. Although the majority of CF mutations--including the most common, delta F508--strongly correlated with pancreatic insufficiency (PI), approximately 10% of the mutant alleles may confer pancreatic sufficiency (PS). To extend this observation, genomic DNA of 538 CF patients with well-documented pancreatic function status were analyzed for a series of known mutations in their CFTR genes. Only 20 of the 25 mutations tested were found in this population. They accounted for 84% of the CF chromosomes, with delta F508 being the most frequent (71%), and the other mutations accounted for less than 5% each. A total of 30 different, complete genotypes could be determined in 394 (73%) of the patients. The data showed that each genotype was associated only with PI or only with PS, but not with both. This result is thus consistent with the hypothesis that PI and PS in CF are predisposed by the genotype at the CFTR locus; the PS phenotype occurs in patients who have one or two mild CFTR mutations, such as R117H, R334W, R347P, A455E, and P574H, whereas the PI phenotype occurs in patients with two severe alleles, such as delta F508, delta I507, Q493X, G542X, R553X, W1282X, 621 + 1G---T, 1717-1G---A, 556delA, 3659delC, I148T, G480C, V520F, G551D, and R560T.</description><subject>Alleles</subject><subject>Amino Acid Sequence</subject><subject>Child</subject><subject>Chromosome Deletion</subject><subject>Chromosome Mapping</subject><subject>Codon - genetics</subject><subject>cystic fibrosis</subject><subject>Cystic Fibrosis - genetics</subject><subject>Cystic Fibrosis - physiopathology</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator</subject><subject>DNA - genetics</subject><subject>Exons</subject><subject>Frameshift Mutation</subject><subject>function</subject><subject>Genotype</subject><subject>Humans</subject><subject>Introns</subject><subject>man</subject><subject>Membrane Proteins - genetics</subject><subject>Mutation</subject><subject>mutations</subject><subject>pancreas</subject><subject>Pancreas - physiopathology</subject><subject>phenotypes</subject><issn>0002-9297</issn><issn>1537-6605</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><recordid>eNqFkE9LxDAUxIMoa139CEJP3gr507y0F0EW3RUWvOi5pOmrRtqkJq243966LqInT495M_wY5ogkTAqVAVB5TBJKKc9KXqpTchbjK6WMFVQsyIIJBZRBQjZrdDhakzY4Yuit06P1LvVtih_eBOswHbQzAfVXqJ2c2fvWpWYX9y9bBx9tPCcnre4iXhzukjzd3T6uNtn2YX2_utlmAy_5mOU54xxzZHVNtSkx57osJQjgTQtKCSy0qlEUDKQpZK7rAkQLrYBmVhSMWJLrb-4w1T02Bt0YdFcNwfY67CqvbfXXcfalevbvFYOCS6lmwNUBEPzbhHGsehsNdp126KdYqXkuYMD_Dc4ZYHLec0kuf1f66XIYWXwC60V6sg</recordid><startdate>19920601</startdate><enddate>19920601</enddate><creator>Kristidis, P</creator><creator>Bozon, D</creator><creator>Corey, M</creator><creator>Markiewicz, D</creator><creator>Rommens, J</creator><creator>Tsui, L C</creator><creator>Durie, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T3</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19920601</creationdate><title>Genetic determination of exocrine pancreatic function in cystic fibrosis</title><author>Kristidis, P ; Bozon, D ; Corey, M ; Markiewicz, D ; Rommens, J ; Tsui, L C ; Durie, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p292t-44122e4e1bb0ac9e42a9956362df6773e8a7be38165c854ab863f6f36d85406c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Alleles</topic><topic>Amino Acid Sequence</topic><topic>Child</topic><topic>Chromosome Deletion</topic><topic>Chromosome Mapping</topic><topic>Codon - genetics</topic><topic>cystic fibrosis</topic><topic>Cystic Fibrosis - genetics</topic><topic>Cystic Fibrosis - physiopathology</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator</topic><topic>DNA - genetics</topic><topic>Exons</topic><topic>Frameshift Mutation</topic><topic>function</topic><topic>Genotype</topic><topic>Humans</topic><topic>Introns</topic><topic>man</topic><topic>Membrane Proteins - genetics</topic><topic>Mutation</topic><topic>mutations</topic><topic>pancreas</topic><topic>Pancreas - physiopathology</topic><topic>phenotypes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kristidis, P</creatorcontrib><creatorcontrib>Bozon, D</creatorcontrib><creatorcontrib>Corey, M</creatorcontrib><creatorcontrib>Markiewicz, D</creatorcontrib><creatorcontrib>Rommens, J</creatorcontrib><creatorcontrib>Tsui, L C</creatorcontrib><creatorcontrib>Durie, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Human Genome Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of human genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kristidis, P</au><au>Bozon, D</au><au>Corey, M</au><au>Markiewicz, D</au><au>Rommens, J</au><au>Tsui, L C</au><au>Durie, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic determination of exocrine pancreatic function in cystic fibrosis</atitle><jtitle>American journal of human genetics</jtitle><addtitle>Am J Hum Genet</addtitle><date>1992-06-01</date><risdate>1992</risdate><volume>50</volume><issue>6</issue><spage>1178</spage><epage>1184</epage><pages>1178-1184</pages><issn>0002-9297</issn><eissn>1537-6605</eissn><abstract>We showed elsewhere that the pancreatic function status of cystic fibrosis (CF) patients could be correlated to mutations in the CF transmembrane conductance regulator (CFTR) gene. Although the majority of CF mutations--including the most common, delta F508--strongly correlated with pancreatic insufficiency (PI), approximately 10% of the mutant alleles may confer pancreatic sufficiency (PS). To extend this observation, genomic DNA of 538 CF patients with well-documented pancreatic function status were analyzed for a series of known mutations in their CFTR genes. Only 20 of the 25 mutations tested were found in this population. They accounted for 84% of the CF chromosomes, with delta F508 being the most frequent (71%), and the other mutations accounted for less than 5% each. A total of 30 different, complete genotypes could be determined in 394 (73%) of the patients. The data showed that each genotype was associated only with PI or only with PS, but not with both. This result is thus consistent with the hypothesis that PI and PS in CF are predisposed by the genotype at the CFTR locus; the PS phenotype occurs in patients who have one or two mild CFTR mutations, such as R117H, R334W, R347P, A455E, and P574H, whereas the PI phenotype occurs in patients with two severe alleles, such as delta F508, delta I507, Q493X, G542X, R553X, W1282X, 621 + 1G---T, 1717-1G---A, 556delA, 3659delC, I148T, G480C, V520F, G551D, and R560T.</abstract><cop>United States</cop><pmid>1376016</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9297
ispartof American journal of human genetics, 1992-06, Vol.50 (6), p.1178-1184
issn 0002-9297
1537-6605
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1682557
source Open Access: PubMed Central
subjects Alleles
Amino Acid Sequence
Child
Chromosome Deletion
Chromosome Mapping
Codon - genetics
cystic fibrosis
Cystic Fibrosis - genetics
Cystic Fibrosis - physiopathology
Cystic Fibrosis Transmembrane Conductance Regulator
DNA - genetics
Exons
Frameshift Mutation
function
Genotype
Humans
Introns
man
Membrane Proteins - genetics
Mutation
mutations
pancreas
Pancreas - physiopathology
phenotypes
title Genetic determination of exocrine pancreatic function in cystic fibrosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A58%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20determination%20of%20exocrine%20pancreatic%20function%20in%20cystic%20fibrosis&rft.jtitle=American%20journal%20of%20human%20genetics&rft.au=Kristidis,%20P&rft.date=1992-06-01&rft.volume=50&rft.issue=6&rft.spage=1178&rft.epage=1184&rft.pages=1178-1184&rft.issn=0002-9297&rft.eissn=1537-6605&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72976162%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p292t-44122e4e1bb0ac9e42a9956362df6773e8a7be38165c854ab863f6f36d85406c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16261580&rft_id=info:pmid/1376016&rfr_iscdi=true